Literature DB >> 16930371

Analysis of the effect of aluminum in drinking water and transferrin C2 allele on Alzheimer's disease.

V Rondeau1, A Iron, L Letenneur, D Commenges, F Duchêne, B Arveiler, J-F Dartigues.   

Abstract

Although highly controversial, the hypothesis of a link between aluminum (Al) in drinking water and Alzheimer's disease (AD) has been supported by several epidemiological studies. Transferrin (Tf) is a major transport protein for both iron and Al. Moreover, it has been demonstrated that defective binding of iron and Al to the Tf variant C2 could be present in AD. Individuals carrying the Tf C2 allele might therefore be at greater risk of developing AD. We investigated whether the Tf C2 allele might be responsible for susceptibility to AD in a sample of 292 subjects (with 55 AD) aged > or = 75 years from south-west France, some exposed to high levels of Al in tap water (n = 181 subjects) and others to low levels of Al (n = 111 subjects). We also examined the combined genetic effects of Tf C2 and epsilon4 allele of apolipoprotein E gene (ApoE). Logistic regression analysis showed that neither Tf C2 nor its interaction with Al or with the epsilon4 allele of the ApoE were significantly associated with the risk of AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16930371      PMCID: PMC1971111          DOI: 10.1111/j.1468-1331.2006.01339.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  17 in total

1.  Human transferrin (Tf): a single mutation at codon 570 determines Tf C1 or Tf C2 variant.

Authors:  K Namekata; F Oyama; M Imagawa; Y Ihara
Journal:  Hum Genet       Date:  1997-09       Impact factor: 4.132

2.  The Paquid epidemiological program on brain ageing.

Authors:  J F Dartigues; M Gagnon; P Barberger-Gateau; L Letenneur; D Commenges; C Sauvel; P Michel; R Salamon
Journal:  Neuroepidemiology       Date:  1992       Impact factor: 3.282

3.  Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease.

Authors:  J Savory; Y Huang; M R Wills; M M Herman
Journal:  Neurotoxicology       Date:  1998-04       Impact factor: 4.294

4.  Increased frequency of the transferrin C2 subtype in Alzheimer's disease.

Authors:  S J van Rensburg; M E Carstens; F C Potocnik; A K Aucamp; J J Taljaard
Journal:  Neuroreport       Date:  1993-09-10       Impact factor: 1.837

5.  Association of transferrin C2 allele with late-onset Alzheimer's disease.

Authors:  K Namekata; M Imagawa; A Terashi; S Ohta; F Oyama; Y Ihara
Journal:  Hum Genet       Date:  1997-12       Impact factor: 4.132

6.  Geographical relation between Alzheimer's disease and aluminum in drinking water.

Authors:  C N Martyn; D J Barker; C Osmond; E C Harris; J A Edwardson; R F Lacey
Journal:  Lancet       Date:  1989-01-14       Impact factor: 79.321

7.  Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

Authors:  A M Saunders; W J Strittmatter; D Schmechel; P H George-Hyslop; M A Pericak-Vance; S H Joo; B L Rosi; J F Gusella; D R Crapper-MacLachlan; M J Alberts
Journal:  Neurology       Date:  1993-08       Impact factor: 9.910

8.  Human transferrin polymorphism.

Authors:  M I Kamboh; R E Ferrell
Journal:  Hum Hered       Date:  1987       Impact factor: 0.444

9.  Common and rare genotypes of human apolipoprotein E determined by specific restriction profiles of polymerase chain reaction-amplified DNA.

Authors:  P Richard; G Thomas; M P de Zulueta; J L De Gennes; M Thomas; A Cassaigne; G Béréziat; A Iron
Journal:  Clin Chem       Date:  1994-01       Impact factor: 8.327

10.  Defective gallium-transferrin binding in Alzheimer disease and Down syndrome: possible mechanism for accumulation of aluminium in brain.

Authors:  G Farrar; P Altmann; S Welch; O Wychrij; B Ghose; J Lejeune; J Corbett; V Prasher; J A Blair
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321

View more
  5 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

2.  Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease.

Authors:  J S K Kauwe; S Bertelsen; K Mayo; C Cruchaga; R Abraham; P Hollingworth; D Harold; M J Owen; J Williams; S Lovestone; J C Morris; A M Goate
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-06-05       Impact factor: 3.568

3.  Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men.

Authors:  George Bartzokis; Po H Lu; Todd A Tishler; Douglas G Peters; Anastasia Kosenko; Katherine A Barrall; J Paul Finn; Pablo Villablanca; Gerhard Laub; Lori L Altshuler; Daniel H Geschwind; Jim Mintz; Elizabeth Neely; James R Connor
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 4.  Pathology supported genetic testing and treatment of cardiovascular disease in middle age for prevention of Alzheimer's disease.

Authors:  Maritha J Kotze; Susan J van Rensburg
Journal:  Metab Brain Dis       Date:  2012-04-19       Impact factor: 3.584

5.  Genetic variants of transferrin in cystic fibrosis.

Authors:  E Marklová; Z Albahri; H Vanícek; P Dedek; M Valis; M Kopácová; V Vávrová
Journal:  J Inherit Metab Dis       Date:  2008-02-22       Impact factor: 4.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.